MESQUITE, NV / ACCESSWIRE / December 14, 2016 / Cannabis Sativa (CBDS) announces that it has acquired several Federally Registered marks to augment its intellectual property portfolio including Cannabis*Sativa®, DISPENSARxY®, and CannaRx®. "We believe that having a strong IP portfolio is essential to our on-going branding emphasis," said CBDS President David Tobias. "A recent article in High Times Magazine stated that "the next quantum leap in the cannabis industry won't be in banking or tax codes, it'll be in branding and intellectual property," and we continue staking our claim." "The marks are currently in the process of "assignment of ownership" from the seller, and depending on the workload of the USPTO, assignment can take several weeks to complete," Tobias stated.
The IP identifiers are Cannabis*Sativa®, Registration Number 4,868,623, DISPENSARxY®, Registration Number 4,642,830 and CannaRx®, Registration Number 4,725,687. The Marks are registered in CL 35 under Goods and Services:
Goods and Services
IC 035. US 100 101 102. G & S: Business consultation services in the field of telling others how to bring together a variety of industrial hemp based products so as to enable their consumers to be aware of the health benefits of such goods and to view and purchase such goods. FIRST USE: 20140416. FIRST USE IN COMMERCE: 20140416
This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company's success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
1646 West Pioneer Blvd Suite 120
Mesquite, NV 89027
SOURCE: Cannabis Sativa, Inc.